International >> Patients >> References


  1. Kinney et al. Trasluminal Angioplasty: A Mechanical-Pathophysiological Correlation of its Physical Mechanisms. Radiology. 1984.

  2. Wild SH, Byrne CD, Tzoulaki I, Lee AJ, Rumley A, Lowe GD, Fowkes FG. Metabolic syndrome, haemostatic and inflammatory markers, cerebrovascular and peripheral arterial disease: The Edinburgh Artery Study. Atherosclerosis. 2009 Apr;203(2):604-9.

  3. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004; 110; 738-743.

  4. Criqui MH. Peripheral arterial disease--epidemiological aspects. Vasc Med. 2001;6(3 Suppl):3-7.

  5. Harris K. The WorldWide Burden of Peripheral Artery Disease. Available at

  6. Creager MA. L?scher TF. Pathophysiology, Clinical Consequences, and Medical Therapy: Part I. Circulation. 2003;108:1527-1532.

  7. SIGN. Diagnosis and management of peripheral arterial disease. A national clinical guideline. 2006.

  8. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med. 2001; 344(21):1608-21.

  9. Norgren L, Hiatt WR, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Available at:

  10. Matsi PJ, Manninen HI. Complications of Lower-Limb Percutaneous Transluminal Angioplasty: A Prospective Analysis of 410 Procedures on 295 Consecutive Patients. Cardiovasc Intervent Radiol. 1998; 21:361 – 366.

  11. B Axisal, G Fishwick, A Bolia, MM Thompson, NJM London, PRF Bell, AR Naylor. Complications following peripheral angioplasty. Ann R Coll Surg Engl 2002; 84: 39-42.

  12. Burns BJ, Phillips AJ, Fox A, Boardman P, Phillips-Hughes J. The Timing and Frequency of Complications After Peripheral Percutaneous Transluminal Angioplasty and Iliac Stenting: Is a Change from Inpatient to Outpatient Therapy Feasible? Cardiovasc Intervent Radiol (2000) 23:452–456.

  13. Baril et al. Outcomes of endovascular interventions for TASC II B and C femoropopliteal lesions. J Vasc Surg. 2008;48:627-33.

  14. Becquemin JP, Cavillon A, Allaire E, Haiduc F, Desgranges P. Iliac and Femoropopliteal Lesions: Evaluation of Balloon Angioplasty and Classical Surgery. J Endo Surg:2(1); 42–50.

  15. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Guidelines of the Management of Patients with PAD (lower extremity, Renal, mesenteric, and abdominal aortic): executive summary. Journal of the American College of Cardiology 2006; 47 (6); 1239-1312.

  16. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005; 366: 1925–34.
a site by razgroup © 2011 Angioslide. All Rights Reserved. Careers Legal Notice Site Map